BridgeMD
New treatment option for Refractory Epilepsy
Official title Effect of Blue Light on Vagus Nerve Stimulation in Patients With Refractory Epilepsy
ClinicalTrials.gov ID: NCT06304389
What this study is testing
- What it's testing
- Vagus nerve stimulation (VNS) is an adjunctive treatment for refractory epilepsy. Although widely used, there is still a substantial number of patients with insufficient response.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60. Healthy volunteers may be eligible.
You may be able to join if
- Patients:
- VNS implanted since at least 3 months age \>18-60 years; IQ \>55 on Wechsler scale (normal status or mild cognitive impairment)
- healthy participants aged between 18 and 35 years without any medical history (neurological / psychiatric disease)
You likely can't join if
- Patients:
- other medical implanted devices than VNS, ocular diseases
- Helthy participants:
- medical implanted devices, cerebral trauma, ocular disease
The study team makes the final eligibility decision.
Where it's taking place
- Woluwe-Saint-Lambert, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Woluwe-Saint-Lambert, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.